| 2026 |
| 11/11 | (IR情報)15:30 2027年3月期第2四半期(中間期)決算説明会資料 |
| 11/11 | (IR情報)15:30 2027年3月期第2四半期(中間期)決算短信〔日本基準〕(連結) |
| 11/11 | 228 | 236 | 228 | 233 | -1.27% | 34,900 | - | -6.43% |
| 11/10 | 235 | 236 | 227 | 236 | +3.06% | 21,300 | - | -5.6% |
| 11/09 | 221 | 230 | 221 | 229 | +3.62% | 15,200 | - | -8.4% |
| 11/06 | 227 | 233 | 216 | 221 | -5.56% | 49,900 | - | -12.3% |
| 11/05 | 231 | 238 | 228 | 234 | +1.74% | 31,100 | - | -7.51% |
| 11/04 | (IR情報)13:30 化粧品ブランド「aeonia(エオニア)」が雑誌『BRUTUS』の「Brutus Best Beauty」に掲載 |
| 11/04 | 235 | 235 | 226 | 230 | -3.36% | 36,800 | - | -9.09% |
| 11/02 | 241 | 241 | 235 | 238 | -2.06% | 11,800 | - | -6.3% |
| 10/30 | 245 | 248 | 241 | 243 | -1.22% | 20,200 | - | -4.71% |
| 10/29 | 251 | 251 | 245 | 246 | -2.77% | 20,400 | - | -3.91% |
| 10/28 | 250 | 256 | 248 | 253 | +2.02% | 16,100 | - | -1.17% |
| 10/27 | 252 | 252 | 247 | 248 | -0.8% | 10,300 | - | -3.5% |
| 10/26 | (IR情報)16:00 バイオレットライト刺激による脳ネットワークの変化をMRIで確認 |
| 10/26 | 247 | 250 | 246 | 250 | -0.4% | 6,400 | - | -2.72% |
| 10/23 | 255 | 258 | 247 | 251 | -1.95% | 73,500 | - | -2.71% |
| 10/22 | 263 | 263 | 254 | 256 | -1.54% | 27,700 | - | -0.78% |
| 10/21 | 256 | 262 | 256 | 260 | -0.38% | 15,300 | - | +0.78% |
| 10/20 | 261 | 263 | 258 | 261 | -0.76% | 30,800 | - | +1.16% |
| 10/19 | (IR情報)15:30 老齢犬におけるバイオレットライト照射による認知機能への影響 |
| 10/19 | 264 | 265 | 260 | 263 | +1.94% | 15,600 | - | +1.54% |
| 10/16 | 255 | 262 | 255 | 258 | +1.18% | 28,900 | - | -0.77% |
| 10/15 | 265 | 265 | 255 | 255 | -3.77% | 15,700 | - | -2.3% |
| 10/14 | 257 | 265 | 257 | 265 | +2.32% | 26,400 | - | +0.76% |
| 10/13 | (IR情報)15:30 坪田ラボが研究を重ねてきたクロセチンを配合した「ロートV5 ビジョンパワー」がロート製薬株式会社より新発売 |
| 10/13 | 258 | 263 | 254 | 259 | -0.38% | 29,300 | - | -2.26% |
| 10/09 | 253 | 261 | 251 | 260 | +1.56% | 39,000 | - | -2.26% |
| 10/08 | 256 | 263 | 255 | 256 | -1.16% | 25,800 | - | -4.48% |
| 10/07 | 266 | 267 | 256 | 259 | -2.26% | 85,200 | - | -3.72% |
| 10/06 | 282 | 285 | 260 | 265 | +6% | 271,800 | - | -2.21% |
| 10/05 | 251 | 259 | 250 | 250 | -0.4% | 21,500 | - | -8.09% |
| 10/02 | 258 | 258 | 250 | 251 | -2.71% | 7,500 | - | -8.06% |
| 10/01 | 254 | 260 | 252 | 258 | +2.38% | 13,400 | - | -5.84% |
| 09/30 | 254 | 271 | 250 | 252 | +2.44% | 23,800 | - | -8.36% |
| 09/29 | 256 | 256 | 242 | 246 | -3.91% | 36,300 | - | -10.87% |
| 09/28 | 258 | 261 | 253 | 256 | -0.39% | 23,000 | - | -7.58% |
| 09/25 | 259 | 262 | 257 | 257 | -0.77% | 15,600 | - | -7.55% |
| 09/24 | 264 | 264 | 255 | 259 | -1.89% | 25,600 | - | -7.17% |
| 09/18 | 256 | 269 | 256 | 264 | +1.54% | 15,000 | - | -5.71% |
| 09/17 | 255 | 267 | 255 | 260 | +1.56% | 24,100 | - | -7.14% |
| 09/16 | 270 | 270 | 256 | 256 | -4.48% | 59,300 | - | -8.9% |
| 09/15 | (IR情報)15:30 各国の眼科関連学会・シンポジウムに相次いで登壇 |
| 09/15 | 254 | 271 | 254 | 268 | +4.28% | 51,700 | - | -4.96% |
| 09/14 | 256 | 261 | 252 | 257 | 0% | 35,700 | - | -8.87% |
| 09/11 | (IR情報)15:30 「Heinrich Meibom Distinguished Lecture Award」を受賞 |
| 09/11 | 251 | 260 | 251 | 257 | -3.38% | 49,400 | - | -8.87% |
| 09/10 | 262 | 270 | 261 | 266 | -4.32% | 73,600 | - | -5.34% |
| 09/09 | 285 | 289 | 277 | 278 | -2.8% | 36,300 | - | -1.07% |
| 09/08 | 299 | 300 | 285 | 286 | -2.39% | 40,100 | - | +2.14% |
| 09/07 | (IR情報)15:30 ファルストマ株式会社との共同研究契約締結に関するお知らせ |
| 09/07 | 298 | 302 | 292 | 293 | -3.3% | 45,500 | - | +5.4% |
| 09/04 | 305 | 305 | 298 | 303 | +1% | 59,500 | - | +9.78% |
| 09/03 | 295 | 302 | 295 | 300 | +1.69% | 39,800 | - | +9.49% |
| 09/02 | 299 | 300 | 290 | 295 | -1.34% | 44,300 | - | +8.46% |
| 09/01 | 298 | 303 | 295 | 299 | +0.34% | 57,900 | - | +11.15% |
| 08/31 | 289 | 299 | 282 | 298 | +2.76% | 38,800 | - | +11.61% |
| 08/28 | 290 | 299 | 289 | 290 | 0% | 59,200 | - | +9.43% |
| 08/27 | 289 | 292 | 286 | 290 | +1.4% | 37,700 | - | +9.85% |
| 08/26 | 279 | 289 | 276 | 286 | +2.51% | 66,300 | - | +9.16% |
| 08/26 | (空売り報告)Barclays Capital Securities Ltd 127,000株(0.48%)-0.09%義務消失 |
| 08/25 | 278 | 282 | 274 | 279 | +2.2% | 33,000 | - | +7.31% |
| 08/24 | 275 | 277 | 271 | 273 | -1.44% | 25,800 | - | +5.81% |
| 08/21 | 280 | 283 | 273 | 277 | -1.42% | 39,500 | - | +7.78% |
| 08/20 | 282 | 287 | 279 | 281 | +0.36% | 111,800 | - | +10.2% |
| 08/19 | (IR情報)15:30 屋外活動時間と視神経乳頭周辺の脈絡膜厚との関連を示唆する論文を発表 |
| 08/19 | 282 | 283 | 274 | 280 | +0.36% | 46,600 | - | +10.67% |
| 08/18 | 282 | 282 | 277 | 279 | +1.45% | 16,300 | - | +10.71% |
| 08/17 | 277 | 283 | 274 | 275 | -0.72% | 50,800 | - | +10% |
| 08/17 | (空売り報告)Barclays Capital Securities Ltd 148,600株(0.57%)-0.03% |
| 08/14 | 276 | 277 | 272 | 277 | +0.36% | 26,300 | - | +11.24% |
| 08/14 | (空売り報告)Barclays Capital Securities Ltd 156,100株(0.6%)+0.02% |
| 08/13 | 274 | 278 | 270 | 276 | +0.36% | 63,000 | - | +11.29% |
| 08/12 | (IR情報)15:30 営業外収益(助成金収入)の計上に関するお知らせ |
| 08/12 | (IR情報)15:30 2027年3月期第1四半期決算短信〔日本基準〕(非連結) |
| 08/12 | 274 | 277 | 267 | 275 | +2.23% | 48,500 | - | +11.34% |
| 08/10 | 261 | 269 | 260 | 269 | +3.46% | 37,000 | - | +9.8% |
| 08/07 | 250 | 261 | 249 | 260 | +3.17% | 56,600 | - | +6.56% |
| 08/06 | 254 | 254 | 250 | 252 | -0.79% | 19,200 | - | +3.28% |
| 08/05 | 247 | 254 | 247 | 254 | +2.83% | 40,100 | - | +4.53% |
| 08/05 | (空売り報告)Barclays Capital Securities Ltd 151,400株(0.58%)-0.11% |
| 08/04 | (IR情報)12:30 「日経・東証IRフェア 2026」初出展のお知らせ |
| 08/04 | 248 | 252 | 246 | 247 | -0.4% | 29,300 | - | +2.07% |
| 08/03 | 246 | 250 | 242 | 248 | +0.4% | 42,400 | - | +2.9% |
| 07/31 | 238 | 247 | 238 | 247 | +2.49% | 45,700 | - | +2.92% |
| 07/30 | 240 | 242 | 237 | 241 | +0.42% | 43,500 | - | +0.84% |
| 07/29 | 235 | 244 | 235 | 240 | +1.27% | 61,900 | - | +0.84% |
| 07/28 | 243 | 243 | 237 | 237 | -2.47% | 63,600 | - | 0% |
| 07/27 | 244 | 252 | 241 | 243 | -0.41% | 82,900 | - | +2.97% |
| 07/27 | (空売り報告)Barclays Capital Securities Ltd 179,700株(0.69%)-0.02% |
| 07/24 | 257 | 258 | 240 | 244 | -10.62% | 312,900 | - | +3.83% |
| 07/23 | 277 | 288 | 268 | 273 | +17.17% | 1,068,800 | - | +16.67% |
| 07/22 | (IR情報)15:30 「TLG-001」の治験総括報告書提出に伴うマイルストーン達成および対価受領確定のお知らせ |
| 07/22 | 236 | 237 | 226 | 233 | -1.27% | 42,900 | - | 0% |
| 07/22 | (空売り報告)Barclays Capital Securities Ltd 186,900株(0.71%)+0.09% |
| 07/21 | 236 | 239 | 233 | 236 | 0% | 15,700 | - | +1.72% |
| 07/21 | (空売り報告)Barclays Capital Securities Ltd 160,400株(0.62%)-0.17% |
| 07/17 | 237 | 239 | 229 | 236 | -0.42% | 15,200 | - | +1.72% |
| 07/16 | 230 | 241 | 230 | 237 | +0.85% | 17,700 | - | +2.6% |
| 07/15 | 236 | 243 | 235 | 235 | -1.67% | 12,100 | - | +2.17% |
| 07/14 | 239 | 242 | 230 | 239 | 0% | 30,100 | - | +3.91% |
| 07/13 | 247 | 248 | 236 | 239 | -1.65% | 40,100 | - | +4.37% |
| 07/13 | (空売り報告)Barclays Capital Securities Ltd 205,300株(0.79%)-0.02% |
| 07/10 | 242 | 247 | 240 | 243 | -0.41% | 13,200 | - | +6.58% |
| 07/09 | 247 | 247 | 240 | 244 | -2.4% | 53,300 | - | +7.02% |
| 07/08 | 270 | 271 | 249 | 250 | +1.63% | 206,800 | - | +10.13% |
| 07/08 | (空売り報告)Barclays Capital Securities Ltd 210,700株(0.81%)+0.07% |
| 07/07 | (IR情報)15:30 マイボーム腺機能不全治療薬TLM-001、第IIa相臨床試験臨床試験においてLPOを達成 |
| 07/07 | 241 | 247 | 241 | 246 | +0.82% | 15,400 | - | +8.85% |
| 07/06 | 239 | 250 | 239 | 244 | +2.09% | 38,700 | - | +8.44% |
| 07/03 | 240 | 240 | 232 | 239 | -1.24% | 53,900 | - | +5.75% |
| 07/02 | (IR情報)15:30 海外製薬企業とのライセンス契約に基づく最終マイルストーン達成および収益計上に関するお知らせ |
| 07/02 | 231 | 242 | 231 | 242 | +4.31% | 23,800 | - | +7.08% |
| 07/01 | 231 | 234 | 229 | 232 | +1.31% | 10,000 | - | +2.2% |
| 06/30 | 226 | 229 | 222 | 229 | +2.23% | 15,200 | - | +0.88% |
| 06/29 | 220 | 226 | 220 | 224 | +1.36% | 8,000 | - | -1.75% |
| 06/26 | 217 | 225 | 217 | 221 | -0.45% | 15,300 | - | -3.49% |
| 06/25 | (IR情報)15:30 事業計画及び成長可能性に関する事項 |
| 06/25 | (IR情報)15:30 支配株主等に関する事項について |
| 06/25 | 216 | 222 | 215 | 222 | +2.78% | 18,100 | - | -3.48% |
| 06/24 | (IR情報)16:00 (開示事項の経過)子会社の異動を伴う株式取得に関するお知らせ |
| 06/24 | (IR情報)14:00 慶應義塾大学殿町タウンキャンパスに共同研究拠点を開設 |
| 06/24 | 217 | 223 | 216 | 216 | 0% | 17,600 | - | -6.9% |
| 06/23 | 218 | 218 | 216 | 216 | -1.37% | 10,200 | - | -7.69% |
| 06/22 | 216 | 230 | 216 | 219 | 0% | 37,200 | - | -7.2% |
| 06/19 | (5%ルール)Cantor Fitzgerald Europe(18.63%) |
| 06/19 | 223 | 225 | 213 | 219 | -3.95% | 56,500 | - | -7.98% |
| 06/18 | 232 | 232 | 222 | 228 | -0.44% | 40,400 | - | -5% |
| 06/17 | (IR情報)16:00 第三者割当による第8回新株予約権、第9回新株予約権及び第10回新株予約権の払込完了に関するお知らせ |
| 06/17 | 215 | 230 | 215 | 229 | +3.15% | 37,500 | - | -5.76% |
| 06/16 | (IR情報)16:00 骨髄ドナーの違いが腸内細菌叢移植後の腸内細菌の定着に影響する可能性を示唆 |
| 06/16 | 227 | 227 | 219 | 222 | -0.45% | 29,700 | - | -9.39% |
| 06/16 | (空売り報告)Barclays Capital Securities Ltd 192,500株(0.74%)+0.06% |
| 06/12 | (空売り報告)Barclays Capital Securities Ltd 176,100株(0.68%)-0.02% |
| 06/10 | (空売り報告)Barclays Capital Securities Ltd 181,500株(0.7%)+0.12% |